Business Description
Hua Medicine
ISIN : KYG4644K1022
Compare
Compare
Traded in other countries / regions
02552.Hong KongHUMDF.USA IPO Date
2018-09-14Description
Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.92 | |||||
| Equity-to-Asset | -0.02 | |||||
| Debt-to-Equity | -8.21 | |||||
| Debt-to-EBITDA | -1.23 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -3.9 | |||||
| Beneish M-Score | -3.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 26 | |||||
| 3-Year EPS without NRI Growth Rate | 20.9 | |||||
| 3-Year Book Growth Rate | -50.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.27 | |||||
| 9-Day RSI | 55.92 | |||||
| 14-Day RSI | 51.52 | |||||
| 3-1 Month Momentum % | 42.5 | |||||
| 6-1 Month Momentum % | 14 | |||||
| 12-1 Month Momentum % | -22.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.87 | |||||
| Quick Ratio | 4.64 | |||||
| Cash Ratio | 4.3 | |||||
| Days Inventory | 242.65 | |||||
| Days Sales Outstanding | 74.52 | |||||
| Days Payable | 339.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.9 | |||||
| Shareholder Yield % | -4.67 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.58 | |||||
| Operating Margin % | -329.46 | |||||
| Net Margin % | -243.32 | |||||
| FCF Margin % | 376.03 | |||||
| ROE % | -282.89 | |||||
| ROA % | -17.42 | |||||
| ROIC % | -110.2 | |||||
| 3-Year ROIIC % | 108.64 | |||||
| ROC (Joel Greenblatt) % | -222.06 | |||||
| ROCE % | -20.61 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 1.44 | |||||
| PS Ratio | 12.33 | |||||
| Price-to-Free-Cash-Flow | 3.29 | |||||
| Price-to-Operating-Cash-Flow | 3.26 | |||||
| EV-to-EBIT | -1.15 | |||||
| EV-to-EBITDA | -1.34 | |||||
| EV-to-Revenue | 2.71 | |||||
| EV-to-FCF | 0.61 | |||||
| Earnings Yield (Greenblatt) % | -86.96 | |||||
| FCF Yield % | 29.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Hua Medicine Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 117.389 | ||
| EPS (TTM) (HK$) | -0.303 | ||
| Beta | 1.71 | ||
| 3-Year Sharpe Ratio | -0.23 | ||
| 3-Year Sortino Ratio | -0.34 | ||
| Volatility % | 50.1 | ||
| 14-Day RSI | 51.52 | ||
| 14-Day ATR (HK$) | 0.078729 | ||
| 20-Day SMA (HK$) | 1.4465 | ||
| 12-1 Month Momentum % | -22.27 | ||
| 52-Week Range (HK$) | 1.03 - 2.55 | ||
| Shares Outstanding (Mil) | 981.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hua Medicine Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hua Medicine Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hua Medicine Frequently Asked Questions
What is Hua Medicine(HKSE:02552)'s stock price today?
The current price of HKSE:02552 is HK$1.50. The 52 week high of HKSE:02552 is HK$2.55 and 52 week low is HK$1.03.
When is next earnings date of Hua Medicine(HKSE:02552)?
The next earnings date of Hua Medicine(HKSE:02552) is .
Does Hua Medicine(HKSE:02552) pay dividends? If so, how much?
Hua Medicine(HKSE:02552) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers